Twist Bioscience Corporation (TWST) financial statements (2021 and earlier)

Company profile

Business Address 681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End September 30
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments587290138
Cash and cash equivalents3499447
Short-term investments23819691
Restricted cash and investments  0
Receivables252612
Inventory, net of allowances, customer advances and progress billings13127
Inventory13127
Other undisclosed current assets863
Total current assets:634335160
Noncurrent Assets
Operating lease, right-of-use asset3234 
Property, plant and equipment272521
Intangible assets, net (including goodwill)112
Goodwill111
Intangible assets, net (excluding goodwill)001
Restricted cash and investments211
Other noncurrent assets334
Total noncurrent assets:656427
TOTAL ASSETS:700399187
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities242426
Accounts payable9510
Accrued liabilities446
Employee-related liabilities121510
Debt333
Other liabilities331
Other undisclosed current liabilities66 
Total current liabilities:373630
Noncurrent Liabilities
Long-term debt and lease obligation24264
Long-term debt, excluding current maturities114
Operating lease, liability2425 
Liabilities, other than long-term debt000
Other liabilities000
Total noncurrent liabilities:25275
Total liabilities:626335
Stockholders' equity
Stockholders' equity attributable to parent638336152
Additional paid in capital1,129795470
Accumulated other comprehensive income000
Accumulated deficit(491)(458)(319)
Total stockholders' equity:638336152
TOTAL LIABILITIES AND EQUITY:700399187

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
Revenues1019054
Cost of revenue(66)(61)(47)
Gross profit:35297
Operating expenses(152)(169)(116)
Operating loss:(117)(140)(109)
Nonoperating income113
Investment income, nonoperating113
Other nonoperating expense(0)(0)(0)
Interest and debt expense(1)(1)(1)
Loss from continuing operations before income taxes:(117)(140)(107)
Income tax expense(0)(0)(0)
Net loss available to common stockholders, diluted:(117)(140)(108)

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
Net loss:(117)(140)(108)
Other comprehensive income (loss)(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(117)(140)(108)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: